Clinical value of soluble IgG Fc receptor type III in plasma from patients with chronic idiopathic neutropenia

Blood

Volumn 91, Issue 10, 1998, Pages 3962-3966

  Koene, Harry R ^b   De Haas, Masja ^b   Kleijer, Marion ^b   Huizinga, Tom W J ^b   Roos, Dirk ^b   Von Dem Borne, Albert E G Kr ^a  

^a CENTRAL LABORATORY   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; IMMUNOGLOBULIN G;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN POLYMORPHISM;

EID: 0032525094     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.10.3962     Document Type: Article

References (22)

1. De Haas M, Vossebeld PJM, Von dem Borne AEGKr, Roos D: Fcγ receptors of phagocytes. J Lab Clin Med 126:330, 1995
2. Sanders LAM, Van de Winkel JGJ, Rijkers GT, Voorhorst-Ogink MM, De Haas M, Capel PJA, Zegers BJM: Fcγ receptor IIa (CD32) heterogeneity in patients with recurrent bacterial respiratory tract infections. J Infect Dis 170:854, 1994
3. Bredius RGM, Derkx BHF, Fijen CAP, De Wit TPM, De Haas M, Weening RS, Van de Winkel JGJ, Out TA: Fcγ receptor IIa (CD32) polymorphism in fulminant meningococcal septic shock in children. J Infect Dis 170:848, 1994
4. Fijen CAP, Bredius RGM, Kuijper EJ: Polymorphisms of IgG Fc-receptors in meningococcal disease: Risk marker in complement deficient patients. Ann Intern Med 119:636, 1993
5. Salmon JE, Edberg JC, Brogle NL, Kimberly RP: Allelic polymorphisms of human Fcγ receptor IIA and Fcγ receptor IIIB. Independent mechanisms for differences in human phagocyte function. J Clin Invest 89:1274, 1992
6. Fleit HB, Kobasiuk CD, Daly C, Furie R, Levy PC, Webster RO: A soluble form of FcγRIII is present in human serum and other body fluids and is elevated at sites of inflammation. Blood 79:2721, 1992
7. Sautes C, Teillaud C, Mazieres N, Tartour E, Bouchard C, Galinha A, Jourde M, Spagnoli R, Fridman WH: Soluble Fcgamma receptors (sFcγR). Detection in biological fluids; production of a murine recombinant sFcγR biologically active in vitro and in vivo. Immunobiology 185:207, 1992
8. Huizinga TWJ, De Haas M, Kleijer M, Nuijens JH, Roos D, Von dem Borne AEGKr: Soluble Fc gamma receptor III in human plasma originates from release by neutrophils. J Clin Invest 86:416, 1990
9. Huizinga TWJ, De Haas M, Van Oers MHJ, Kleijer M, Vile H, van de Wouw PA, Moulijn A, van Weezel H, Roos D, Von dem Borne AEGKr: The plasma concentration of soluble Fc-gamma-RJII is related to production of neutrophils. Br J Haematol 87:459, 1994
10. Kerst JM, De Haas M, van der Schoot CE, Slaper-Cortenbach ICM, Kleijer M, Von dem Borne AEGKr, Van Oers MHJ: rG-CSF administration to healthy volunteers: Induction of immunophenotypically and functionally altered neutrophils via an effect on myeloid progenitor cells. Blood 82:3265, 1993
11. Homburg CHE, De Haas M, Von dem Borne AEGKr, Verhoeven AJ, Reutelingsperger CPM, Roos D: Human neutrophils lose their surface FcγRIII and acquire Annexin V binding sites during apoptosis in vitro. Blood 85:532, 1995
12. Koene HR, De Haas M, Kleijer M, Roos D, Von dem Borne AFGKr: NA-phenotype-dependent differences in neutrophil FcγRIIIb expression cause differences in plasma levels of soluble FcγRIIIb. Br J Haematol 93:235, 1996
13. Verbeugt FWA, Decary F, Engelfriet CP: Detection of granulocyte allo-antibodies by an indirect immunofluorescence test. Br J Haematol 36:533, 1977
14. De Haas M, Kleijer M, Van Zwieten R, Roos D, Von dem Borne AEGKr: Neutrophil FcγRIIIb deficiency, nature and clinical consequences: A study of 21 individuals from 14 families. Blood 86:2403, 1995
15. Huizinga TWJ, Roos D, Von dem Borne AEGKr: Fc-gamma receptors: Mediators, targets and markers of disease, in Von dem Borne AEGKr (ed): Molecular Immunohaematology. London, UK, Baillere, 1991, p 889
16. Finch SC: Neutrophil disorders-benign, quantitative abnormalities of neutrophils, in Williams WJ, Beutler E, Erslev AJ, Lichtman MA (eds): Hematology. New York, NY, McGraw-Hill, 1983, p 773
17. Shastri KA, Logue GL: Autoimmune neutropenia. Blood 81: 1984, 1993
18. Leino L, Sorvajarvi K, Katajisto J, Laine M, Lilius EM, Pelliniemi TT, Rajamaki A, Silvoniemi P, Nikoskelainen J: Febrile infection changes the expression of IgG Fc receptors and complement receptors in human neutrophils in vivo. Clin Exp Immunol 107:37, 1997
19. Muniz-Diaz E, Madoz P, De la Calle Martin O, Puig L: The polymorphic neutrophil FcγRIIIb deficiency is more frequent than hitherto assumed. Blood 86:3999, 1996
20. Mathiot C, Teillaud JL, Elmalek M, Mosseri V, Euller-Ziegler L, Daragon A, Grosbois B, Michaux JL, Facon T, Bernard JF, Duclos B, Monconduit M, Fridman WH: Correlation between soluble serum CD16 (sCD16) levels and disease stage in patients with multiple myeloma. J Clin Immunol 13:41, 1993
21. Fleit HB, Kobasiuk CD: Soluble FcγRIII is present in lower concentration in the serum of patients with acute myelogenous leukemia (AML): A retrospective study. Leukemia 7:1250, 1993
22. Khayat D, Soubrane C, Andrieu JM, Visonneau S, Eme D, Tourani JM, Beldjord K, Weil M, Fernandez E, Jacquillat C: Changes of soluble CD 16 levels in serum of HIV-infected patients: Correlation with clinical and biological prognostic factors. J Infect Dis 161:430, 1990